Author(s):
Norisca Aliza Putriana, Taofik Rusdiana, Tina Rostinawati, Mohammad Rizki Akbar
Email(s):
t.rusdiana@unpad.ac.id
DOI:
10.52711/0974-360X.2022.00815 
Address:
Norisca Aliza Putriana1, Taofik Rusdiana1*, Tina Rostinawati2, Mohammad Rizki Akbar3
1Department of Pharmaceutical and Formulation Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang KM 21, Jatinangor 45363, Indonesia.
2Department of Biology Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang KM 21, Jatinangor 45363, Indonesia.
3Department of Cardiovascular, Faculty of Medicine, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang KM 21, Jatinangor 45363, Indonesia.
*Corresponding Author
Published In:
Volume - 15,
Issue - 10,
Year - 2022
ABSTRACT:
Warfarin is a type of vitamin K antagonist anticoagulant used to thromboembolic prevention and its maintenance dose differs significantly among patients. Moreover, the factor influencing the dose calculation is known as genetic polymorphism, while the influence of vitamin K intake while the effect of vitamin K intake is still a matter of debate. This study aims to provide an overview of several studies on the effect of vitamin K intake on the stability of the PT-INR value and anticoagulation in warfarin therapy patients. A study was conducted on the effect of vitamin K intake on the PT-INR value stability and anticoagulation in warfarin therapy patients. One study showed that there was no significant correlation between vitamin K usual intake and the anticoagulant effect, while in another, it was found that the stability of this effect is achievable with adequate amounts of the vitamin intake. Furthermore, another study showed that the anticoagulant effect is more stable in patients with excessive vitamin K intake on long-term warfarin use. However, other study showed that INR values will stabilize if vitamin K intake is relatively low. The results from various studies were different, therefore, there is a debate regarding the influence of vitamin K intake on the PT-INR value and anticoagulation.
Cite this article:
Norisca Aliza Putriana, Taofik Rusdiana, Tina Rostinawati, Mohammad Rizki Akbar. Influence of Vitamin K intake on INR and Anticoagulation in outpatients taking Warfarin. Research Journal of Pharmacy and Technology 2022; 15(10):4851-6. doi: 10.52711/0974-360X.2022.00815
Cite(Electronic):
Norisca Aliza Putriana, Taofik Rusdiana, Tina Rostinawati, Mohammad Rizki Akbar. Influence of Vitamin K intake on INR and Anticoagulation in outpatients taking Warfarin. Research Journal of Pharmacy and Technology 2022; 15(10):4851-6. doi: 10.52711/0974-360X.2022.00815 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-10-88
REFERENCES:
1. Ansell JE, Buttaro ML, Thomas O V, Knowlton CH. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force. Ann Pharmacother. 1997 May;31(5):604–15. doi: 10.1177/106002809703100516
2. Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest. 2001 Feb 1;119:22S-38S. doi: 10.1378/chest.119.1_suppl.22
3. Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004 Nov;141(10):745–52. doi: 10.7326/0003-4819-141-10-200411160-00005
4. Hylek EM. Oral anticoagulants. Pharmacologic issues for use in the elderly. Clin Geriatr Med. 2001 Feb;17(1):1–13. doi: 10.1016/s0749-0690(05)70102-6
5. Alias SM, Nair VS, Byju P, Pai PG, Reghu R. A Comparative Study on the effect of Warfarin v/s Acenocoumarol in patients with Atrial fibrillation. Res J Pharm Tech. 2011;14(1):1–5. doi: 10.5958/0974-360X.2021.00001.9
6. Savelieva I, Camm J. Update on atrial fibrillation: part I. Clin Cardiol. 2008 Feb;31(2):55–62. doi: 10.1002/clc.20138
7. Siguret V, Pautas E, Gouin-Thibault I. Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin. Vitam Horm. 2008;78:247–64. doi: 10.1016/S0083-6729(07)00012-X
8. Dang M-TN, Hambleton J, Kayser SR. The influence of ethnicity on warfarin dosage requirement. Ann Pharmacother. 2005 Jun;39(6):1008–12. doi: 10.1345/aph.1E566
9. Shearer MJ, Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost. 2008 Oct;100(4):530–47.
10. Nilamsari WP, Yusuf M, Suharjono, Pertiwi DA, Dery A, Suprapti B, et al. Study of Co-Prescription of Drugs Potentially Interacting with Warfarin in Indonesian Ambulatory patients. J Pharm Tech. 2020;13(8):3833–6. doi: 10.5958/0974-360X.2020.00678.2
11. D’Souza M. Effect of Planned Teaching on knowledge and practice regarding the care of patients receiving Anti-Coagulant Therapy among the Nurses in the Intensive Care Unit in a Selected Hospital. Asian J Nur Edu Res. 2015;5(3):351–62. doi: 10.5958/2349-2996.2015.00072.5
12. Greenblatt DJ, von Moltke LL. Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol. 2005 Feb;45(2):127–32. doi: 10.1177/0091270004271404
13. Bolton-Smith C, Price RJ, Fenton ST, Harrington DJ, Shearer MJ. Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of foods. Br J Nutr. 2000 Apr;83(4):389–99.
14. Nigam M, Verma R, Sharma SK. Synthetic Study of vitamin K3 (Menadione, 2-methyl-1, 4-napthoquinone): A Review. Asian J Res Chem. 2012;5(9):1200–4.
15. Oldenburg J, Watzka M, Rost S, Müller CR. VKORC1: molecular target of coumarins. J Thromb Haemost. 2007 Jul;5 Suppl 1:1–6. doi: 10.1111/j.1538-7836.2007.02549.x
16. Khan T, Wynne H, Wood P, Torrance A, Hankey C, Avery P, et al. Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Br J Haematol. 2004 Mar 1;124:348–54. doi: 10.1046/j.1365-2141.2003.04787.x
17. Park JN, Lee JS, Noh MY, Sung M-K. Association Between Usual Vitamin K Intake and Anticoagulation in Patients Under Warfarin Therapy. Clin Nutr Res [Internet]. 2015/10/31. 2015 Oct;4(4):235–41. doi: 10.7762/cnr.2015.4.4.235
18. de Assis MC, Rabelo ER, Avila CW, Polanczyk CA, Rohde LE. Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized controlled trial. Circulation. 2009 Sep;120(12):1115–22, 3 p following 1122. doi: 10.1161/CIRCULATIONAHA.109.849208
19. Kim KH, Choi WS, Lee JH, Lee H, Yang DH, Chae SC. Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin. Thromb Haemost. 2010 Oct;104(4):755–9. doi: 10.1160/TH10-04-0257
20. Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med. 2004 May;116(10):651–6. doi: 10.1016/j.amjmed.2003.12.036
21. Rombouts EK, Rosendaal FR, van der Meer FJM. Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. Br J Haematol. 2010 May;149(4):598–605. doi: 10.1111/j.1365-2141.2010.08108.x
22. Rasmussen MA, Skov J, Bladbjerg E-M, Sidelmann JJ, Vamosi M, Jespersen J. Multivariate analysis of the relation between diet and warfarin dose. Eur J Clin Pharmacol. 2012 Mar;68(3):321–8. doi: 10.1007/s00228-011-1123-3
23. Zuchinali P, Souza GC, de Assis MCS, Rabelo ER, Rohde LE. Dietary vitamin K intake and stability of anticoagulation with coumarins: evidence derived from a clinical trial. Nutr Hosp. 2012;27(6):1987–92. doi: 10.3305/nh.2012.27.6.6068
24. Walther B, Karl JP, Booth SL, Boyaval P. Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Adv Nutr [Internet]. 2013 Jul 1;4(4):463–73. doi: 10.3945/an.113.003855
25. Holmes M V, Hunt BJ, Shearer MJ. The role of dietary vitamin K in the management of oral vitamin K antagonists. Blood Rev. 2012 Jan;26(1):1–14. doi: 10.1016/j.blre.2011.07.002
26. Schurgers LJ, Shearer MJ, Hamulyák K, Stöcklin E, Vermeer C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood. 2004 Nov;104(9):2682–9. doi: 10.1182/blood-2004-04-1525
27. Lubetsky A, Dekel-Stern E, Chetrit A, Lubin F, Halkin H. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets. Thromb Haemost. 1999 Mar;81(3):396–9.
28. Johnson MA. Influence of vitamin K on anticoagulant therapy depends on vitamin K status and the source and chemical forms of vitamin K. Nutr Rev. 2005 Mar;63(3):91–7. doi: 10.1182/blood-2004-04-1525
29. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2007 Mar;109(6):2419–23. doi: 10.1182/blood-2006-09-049262
30. Loebstein R, Yonath H, Peleg D, Almog S, Rotenberg M, Lubetsky A, et al. Interindividual variability in sensitivity to warfarin--Nature or nurture? Clin Pharmacol Ther. 2001 Aug;70(2):159–64. doi: 10.1067/mcp.2001.117444
31. Zhang YT, Tang ZY. Research progress of warfarin-associated vascular calcification and its possible therapy. J Cardiovasc Pharmacol. 2014 Jan;63(1):76-82.